Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

The Impact of Osteoporosis Medications on Muscle Health in Older Adults

Authors not listed

Nami Safai Haeri · 2023

Abstract

Osteosarcopenia is a geriatric musculoskeletal syndrome characterized by co-existence of osteoporosis and sarcopenia (low skeletal muscle mass, strength, and/or functional capacity). There is strong evidence of overlap between the pathophysiology of osteoporosis and sarcopenia (muscle-bone crosstalk). This research plan will further explore the relationship between bone and muscle, and provide new information about effect of osteoporosis medications on muscle health in older adults who are under treatment for osteoporosis.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-03 MST

Cite this

APA
Anonymous. (2023). The Impact of Osteoporosis Medications on Muscle Health in Older Adults. <em>Nami Safai Haeri</em>. https://clinicaltrials.gov/study/NCT05666310
Vancouver
Anonymous. The Impact of Osteoporosis Medications on Muscle Health in Older Adults. Nami Safai Haeri. 2023.
BibTeX
@misc{anon2023TheImp, title = {The Impact of Osteoporosis Medications on Muscle Health in Older Adults}, author = {Anonymous}, journal = {Nami Safai Haeri}, year = {2023}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings